Market Cap 14.13M
Revenue (ttm) 0.00
Net Income (ttm) 2.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 103,918
Avg Vol 50,184
Day's Range N/A - N/A
Shares Out 32.69M
Stochastic %K 0%
Beta -0.10
Analysts Strong Sell
Price Target $5.67

Company Profile

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer'...

Industry: Biotechnology
Sector: Healthcare
Phone: 416 847 6898
Fax: 416 847 6899
Address:
1920 Yonge Street, Suite 200, Toronto, Canada
ridethewaves3
ridethewaves3 Jul. 2 at 8:10 PM
$PMN they need to stop this bleeding fam. Been holding the bag for a while now.
0 · Reply
Stockttwits619
Stockttwits619 Jul. 2 at 7:03 PM
$PMN Might redo yesterday’s AH …WILL JUMP IN @ 2 59 if she spikes
0 · Reply
Sunny3999
Sunny3999 Jun. 25 at 5:12 PM
$PMN hope for double digits with excellent news
0 · Reply
BKLYN_Bull
BKLYN_Bull Jun. 14 at 8:58 PM
$PMN I’m wondering what everyone’s PT is after potential positive news?
2 · Reply
Sunny3999
Sunny3999 Jun. 10 at 12:18 PM
$PMN time to fly 🛫🔥🚀 Promis Neuroscience $GILD $JNJ $PFE $RHHBY
0 · Reply
Sunny3999
Sunny3999 Jun. 10 at 12:15 PM
$PMN ready to fly 🛫🔥 $ABBV $BMY $MRK $SNY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:36 PM
ProMIS Neurosciences $PMN reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD," said Neil Warma, CEO. $ABBV $BMY $MRK $SNY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:36 PM
$PMN ProMIS Neurosciences reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD," said Neil Warma, CEO. $GILD $JNJ $PFE $RHHBY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:19 PM
$PMN June we will know about the biomarker levels, if the study isn’t stopped, this stock rockets 🚀 $SNY $ABBV $MRK $BMY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:14 PM
$PMN In june we will know about the biomarker levels, if the study isn’t stopped, this stock rocket 🚀 $JNJ $PFE $RHHBY $GILD
0 · Reply
Latest News on PMN
ProMIS Neurosciences Issues Letter to Shareholders

Jan 13, 2025, 10:30 AM EST - 6 months ago

ProMIS Neurosciences Issues Letter to Shareholders


ProMIS Neurosciences, Inc. Announces Leadership Transition

Jan 3, 2024, 7:00 AM EST - 1 year ago

ProMIS Neurosciences, Inc. Announces Leadership Transition


ProMIS Announces Completion of Continuance

Jul 14, 2023, 7:45 AM EDT - 2 years ago

ProMIS Announces Completion of Continuance


ridethewaves3
ridethewaves3 Jul. 2 at 8:10 PM
$PMN they need to stop this bleeding fam. Been holding the bag for a while now.
0 · Reply
Stockttwits619
Stockttwits619 Jul. 2 at 7:03 PM
$PMN Might redo yesterday’s AH …WILL JUMP IN @ 2 59 if she spikes
0 · Reply
Sunny3999
Sunny3999 Jun. 25 at 5:12 PM
$PMN hope for double digits with excellent news
0 · Reply
BKLYN_Bull
BKLYN_Bull Jun. 14 at 8:58 PM
$PMN I’m wondering what everyone’s PT is after potential positive news?
2 · Reply
Sunny3999
Sunny3999 Jun. 10 at 12:18 PM
$PMN time to fly 🛫🔥🚀 Promis Neuroscience $GILD $JNJ $PFE $RHHBY
0 · Reply
Sunny3999
Sunny3999 Jun. 10 at 12:15 PM
$PMN ready to fly 🛫🔥 $ABBV $BMY $MRK $SNY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:36 PM
ProMIS Neurosciences $PMN reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD," said Neil Warma, CEO. $ABBV $BMY $MRK $SNY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:36 PM
$PMN ProMIS Neurosciences reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD," said Neil Warma, CEO. $GILD $JNJ $PFE $RHHBY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:19 PM
$PMN June we will know about the biomarker levels, if the study isn’t stopped, this stock rockets 🚀 $SNY $ABBV $MRK $BMY
0 · Reply
Sunny3999
Sunny3999 Jun. 4 at 4:14 PM
$PMN In june we will know about the biomarker levels, if the study isn’t stopped, this stock rocket 🚀 $JNJ $PFE $RHHBY $GILD
0 · Reply
Glopolon
Glopolon Jun. 1 at 2:03 PM
$PMN Expecting interim analysis soon, but they use up a lot of cash. Will need good data, and probably then another raise.
1 · Reply
Sunny3999
Sunny3999 May. 19 at 5:20 PM
$PMN buying as much as I can! Soon it should reverse up to several $
1 · Reply
JarvisFlow
JarvisFlow May. 12 at 12:30 PM
Maxim Group has adjusted their stance on ProMIS Neurosciences ( $PMN ), setting the rating to Buy with a target price of 3.
1 · Reply
Alex1710
Alex1710 May. 8 at 9:26 PM
$PMN The end is near. In a year from now at most it won't exist.
3 · Reply
Alex1710
Alex1710 May. 8 at 1:22 AM
$PMN Pure scrap.
1 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 6 at 2:32 PM
1 · Reply
7DAYSDIMENSIONS
7DAYSDIMENSIONS May. 1 at 6:48 PM
$PMN Honestly I don't understand people selling at 0.64. Something has to be wrong in their head.
2 · Reply
WAYWARD_SUN
WAYWARD_SUN Apr. 25 at 1:54 PM
0 · Reply
Tigger456
Tigger456 Apr. 21 at 2:45 PM
$PMN For anyone who has a family member or knows someone who is or has suffered from Alzheimer’s, supporting innovative research is the only route to solving it. This company needs more eyes. They’re doing something different and may have a solution.
0 · Reply
7DAYSDIMENSIONS
7DAYSDIMENSIONS Apr. 17 at 4:42 PM
$PMN something cooking?
1 · Reply
Stockttwits619
Stockttwits619 Apr. 15 at 8:24 PM
1 · Reply
JarvisFlow
JarvisFlow Apr. 1 at 2:56 PM
Guggenheim has updated their rating for ProMIS Neurosciences ( $PMN ) to Buy with a price target of 6.
0 · Reply